Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,574,000 | 1,680,000 | 1,655,000 | 1,436,000 | 1,338,000 |
| Cost of Goods | 1,181,000 | 1,253,000 | 1,391,000 | 1,139,000 | 1,025,000 |
| Gross Profit | 393,000 | 427,000 | 264,000 | 297,000 | 313,000 |
| Operating Expenses | 189,000 | 154,000 | 204,000 | 158,000 | 250,000 |
| Operating Income | 204,000 | 273,000 | 60,000 | 139,000 | 63,000 |
| Interest Expense | 44,000 | 45,000 | 47,000 | 49,000 | 50,000 |
| Other Income | 140,000 | 3,000 | 31,000 | 11,000 | 9,000 |
| Pre-tax Income | 300,000 | 231,000 | 44,000 | 101,000 | 22,000 |
| Income Tax | 68,000 | 17,000 | -22,000 | 5,000 | 3,000 |
| Net Income Continuous | 232,000 | 214,000 | 66,000 | 96,000 | 19,000 |
| Net Income | $232,000 | $214,000 | $66,000 | $96,000 | $19,000 |
| EPS Basic Total Ops | 1.41 | 1.30 | 0.40 | 0.58 | 0.11 |
| EPS Basic Continuous Ops | 1.41 | 1.30 | 0.40 | 0.58 | 0.11 |
| EPS Diluted Total Ops | 1.37 | 1.27 | 0.39 | 0.57 | 0.10 |
| EPS Diluted Continuous Ops | 1.38 | 1.27 | 0.39 | 0.57 | 0.11 |
| EBITDA(a) | $282,000 | $354,000 | $142,000 | $224,000 | $145,000 |